B
Braidwell’s Neurocrine Biosciences NBIX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $146M | Sell |
1,160,425
-31,500
| -3% | -$3.96M | 4.99% | 3 |
|
|
2025
Q1 | $132M | Buy |
1,191,925
+290,135
| +32% | +$32.1M | 4.63% | 3 |
|
|
2024
Q4 | $123M | Sell |
901,790
-15,884
| -2% | -$2.17M | 3.65% | 4 |
|
|
2024
Q3 | $106M | Buy |
917,674
+158,665
| +21% | +$18.3M | 3% | 7 |
|
|
2024
Q2 | $104M | Buy |
759,009
+28,800
| +4% | +$3.96M | 3.28% | 5 |
|
|
2024
Q1 | $101M | Buy |
730,209
+15,000
| +2% | +$2.07M | 3.25% | 7 |
|
|
2023
Q4 | $94.2M | Sell |
715,209
-252,815
| -26% | -$33.3M | 3.46% | 6 |
|
|
2023
Q3 | $109M | Buy |
968,024
+34,662
| +4% | +$3.9M | 3.44% | 7 |
|
|
2023
Q2 | $88M | Buy |
933,362
+166,562
| +22% | +$15.7M | 2.88% | 8 |
|
|
2023
Q1 | $77.6M | Buy |
+766,800
| New | +$77.6M | 2.56% | 10 |
|